Endomedix is a pioneering biosurgery company based in Newark, NJ, specializing in the development of innovative medical technologies. Their breakthrough platform, PLEXimine, utilizes precision polysaccharide chemistry to enable surgeons to create dynamic and structured medical devices in situ, revolutionizing biosurgery and enhancing patient care in both established and emerging procedures.
With a strong focus on research and development, Endomedix is at the forefront of advancing the field of biosurgery. Their cutting-edge technology has the potential to transform various medical applications, offering new possibilities for surgical interventions and improving outcomes for patients. As a leader in the industry, Endomedix is committed to pushing the boundaries of medical innovation and shaping the future of biosurgery.
Generated from the website